Clinical research study for early-stage cutaneous squamous cell cancer (CSCC)

A potential non-surgical treatment option for adults with early-stage CSCC.

Have you been recently diagnosed with early-stage cutaneous squamous cell cancer (CSCC)?

This website provides information about a clinical study, CLEAR, for adults with early-stage CSCC. CSCC is one of the most common types of skin cancer, which is usually treated with surgery when diagnosed at an early stage. Although surgery is the standard treatment for early-stage CSCC, there is a growing need for non-surgical alternatives.

Clinical studies are essential to investigating potential treatments and are not possible without the people who take part. Everyone involved in this clinical study plays an important role in increasing our understanding of early-stage CSCC, which may help others in the future with this condition.

A CSCC diagnosis may feel overwhelming, and you may feel that you have enough to do without committing to a clinical study. However, you may play a key role in helping to develop therapies that are being studied to help advance our medical knowledge of early-stage CSCC. Every treatment that exists today is available because of study participants who actively took part in research.

Learn more about the CLEAR study and see if it may be an option for you or someone you know.

This clinical trial will use an investigational drug product, the safety and efficacy of which has not been fully evaluated by Regulatory Authorities.